LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF...

Hematological Oncology 2019 / 06 Vol. 37

LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B-CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL)

Gini, G., Tani, M., Bassan, R., Tucci, A., Ballerini, F., Sampaolo, M., Merli, F., Re, F., Annibali, O., Liberati, A., Visco, C., Arcari, A., Storti, S., Fabbri, A., Musuraca, G., Zilioli, V., Cox, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.99_2631
Date:
June, 2019
File:
PDF, 215 KB
english, 2019
Conversion to is in progress
Conversion to is failed